HomeIXC • ASX
add
Invex Therapeutics Ltd
Nakaraang pagsara
$0.070
Sakop ng taon
$0.059 - $0.090
Market cap
5.04M AUD
Average na Volume
7.93K
P/E ratio
44.59
Dividend yield
-
Primary exchange
ASX
Mga balita tungkol sa merkado
Seeking Alpha
7 minuto ang nakalipas
S&P 500 nears Goldman Sachs' target as cash spending outlook dims
0.74%
0.094%
Mga Financial
Income Statement
Kita
Net na kita
| (AUD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 236.09K | -81.03% |
Net na kita | -178.27K | 83.12% |
Net profit margin | — | — |
Kita sa bawat share | — | — |
EBITDA | — | — |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (AUD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 5.81M | -5.61% |
Kabuuang asset | 5.86M | -6.63% |
Kabuuang sagutin | 479.87K | -51.26% |
Kabuuang equity | 5.38M | — |
Natitirang share | 75.15M | — |
Presyo para makapag-book | 1.00 | — |
Return on assets | -10.06% | — |
Return on capital | -10.96% | — |
Cash Flow
Net change in cash
| (AUD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -178.27K | 83.12% |
Cash mula sa mga operasyon | -120.81K | 89.57% |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | -109.30K | 98.66% |
Malayang cash flow | -139.41K | 80.60% |
Tungkol
Itinatag
2019
Website
